Care Providers And Payers Seek New Technologies

Healthcare organizations are embracing innovations and becoming a key training ground to test the medical benefits, technical feasibility, and business viability of new technology breakthroughs. From innovation centers to investment vehicles, healthcare organizations have become critical partners for entrepreneurs. This panel will reveal the changing role healthcare organizations are playing in fostering innovation. Topics may include:

  • What are hospitals and health networks doing to engage with new technology companies?
  • How can a startup get the most out of conducting pilot studies with a healthcare system partner?
  • How do early stage companies work with healthcare systems to generate user experience for their new technologies?
  • How can healthcare organizations share their technical expertise with startups?

This RESI panel will help entrepreneurs navigate complex healthcare systems and bring their companies to the next milestone.


Request a Meeting

Mayank Taneja, Director of Venture Investments, OSF Healthcare Ventures

Mayank is a versatile physician investor, bringing experience from practicing medicine, conducting clinical and translational research and working on healthcare venture and innovation projects. At OSF Ventures, Mayank’s primary role is to source new opportunities in the medtech and digital health space and to help lead due diligence on the clinical and business aspects. Mayank represents OSF Ventures as a Board Observer for InsightRx, Epharmix and Paradigm Diagnostics. Before joining the OSF Ventures team, Mayank worked with the OSF’s usability studies team and helped new device startups in piloting their technologies and performing human factor studies for FDA submission. Prior to joining OSF, he worked at Zimmer Inc. in its post market risk surveillance division as part of the Zimmer Leadership Program. He received his medical degree from Maulana Azad Medical College in India and his MBA from The Ohio State University (Fisher College).


Request a Meeting

Cyril Philip, Principal, Providence Ventures

Cyril Philip is a Principal at Providence Ventures (PV), where he focuses on investments in healthcare technology, tech-enabled services, and digital health. Cyril joined Providence as one of the first hires of the newly formed venture team in 2015. He currently serves as a Board Observer at Binary Fountain and Wildflower Health. Cyril also served on the Board of precision medicine company N-of-One prior to its exit. In addition, he has also participated on the deal teams for PV’s investments in InDemand Interpreting (sold), Intelligent Retinal Imaging Systems, Kyruus, Protenus, and Trilliant Health.

Prior to joining PV, Cyril was at Halyard Capital, where he focused on private equity investments in mid-stage companies in the technology, business services and healthcare sectors. Prior to Halyard, Cyril spent five years at UBS Investment Bank in the Global Healthcare group, where he worked on over 30 transactions across healthcare services/technology, life sciences and medical technology. Cyril graduated from the Tepper School of Business at Carnegie Mellon with a B.S. in Business Administration.

In his free time, Cyril enjoys volunteering, watching sports, and travelling. He sits on the Board of the Northwest Association for Global Affairs, a non-profit based in the Pacific Northwest that promotes experiential education in global affairs for college students in the region. Cyril is a transplant to Seattle from New York.

Request a Meeting

Rajesh Aggarwal, Executive Vice President, Jefferson Strategic Ventures

Rajesh Aggarwal is a clinician in bariatric and minimally invasive surgery, a global academic leader in simulation technologies with respect to health professions’ education, a health care innovator, a speaker and educator, and a successful fundraiser. He undertook his Bachelor’s degree in Social and Political Sciences at the University of Cambridge, and medical school at the Royal Free Hospital School of Medicine. Subsequently, he completed general surgical residency at Imperial College London. Rajesh has continued to maintain an academic and clinical practice, as a Faculty member at Imperial College London, University of Pennsylvania and, most recently at McGill University where he was also charged as Director of the Steinberg Centre for Simulation and Interactive Learning. In 2017, Rajesh took on his role in strategic ventures and partnerships at Thomas Jefferson University and Jefferson Health.

Request a Meeting

Linda Maxwell, Director, Biomedical Zone

Dr. Linda Maxwell is the founding and executive director of the Biomedical Zone, a first-in-class, hospital-embedded business incubator. The Ryerson-affiliated group helps emerging health technology companies by matching them with industry leaders and its strategic partnership with St. Michael’s Hospital. Through her work Maxwell helps strengthen, grow and build Toronto’s leading health-focused technology businesses.

Under the Harvard alum’s leadership, the Biomedical Zone has supported over 160 innovators, facilitated fundraising for startup companies in excess of $15 million dollars in private investment, supported companies through two commercial exits and engaged in twenty-five hospital innovation projects.